Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 28
Merck-Sponsored Report Finds Managers Didn't Conceal Vioxx Concerns
Journal Watch, Arthritis Drugs, September 2006
Federal Judge Vacates $51 Million Vioxx Award, Orders New Trial
Merck Reports Mixed Study Results of COX-2 Arcoxia Risks
FDA Expands Remicade Approval for Psoriatic Arthritis Treatment
Judge Says FDA Authority Preempts Celebrex Failure-to-Warn Claims
Arthritis Drugs - Issue: 27
Arthritis Drugs in the Medical Literature This Month - August 2006
Arthritis Drugs - Issue: 28
Jury Finds Merck Failed to Warn of Vioxx Risks, Awards Plaintiff $51 Million
